Report Detail
Global (United States, European Union and China) Intraveno(IV) Iron Drugs Market Research Report 2019-2025
- RnM3617541 |
- 29 July, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Iron supplements are available in two forms: oral and intravenous. Intravenous iron preparations are superior to oral supplements, as these lead to higher and faster increase in iron and Hb levels. Oral supplements have disadvantages such as GI adverse events, poor adherence, poor gastrointestinal absorption, and non-compliance.
Major drivers of the IV iron drugs market are increase in incidence of iron deficiency, rise in chronic kidney disease patients undergoing dialysis, and surging diabetic population. Increase in iron deficiency anemia in gynecology, oncology, and gastroenterology, noncompliance of oral therapy, and accurate, easy, and convenient access to IV iron dosages drive demand for intravenous iron drugs. However, complex approval process, stringent regulations, drug side effects, nutraceutical alternatives to prevent iron deficiency, and product price are likely to act as major restraints of the IV iron drugs market.
In 2019, the market size of Intraveno(IV) Iron Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Intraveno(IV) Iron Drugs.
This report studies the global market size of Intraveno(IV) Iron Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Intraveno(IV) Iron Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Allergan
AMAG Pharmaceuticals
Galenica
Actavis
American Regent
Sanofi
Luitpold Pharmaceuticals
Fresenius Medical Care
Pharmacosmos
Vifor Pharma
Market Segment by Product Type
Low Molecular Weight Iron Dextran
Ferric Gluconate
Iron Sucrose
Ferric Carboxyl Maltose
Market Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Intraveno(IV) Iron Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Intraveno(IV) Iron Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Intraveno(IV) Iron Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Intraveno(IV) Iron Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Low Molecular Weight Iron Dextran
- 1.3.3 Ferric Gluconate
- 1.3.4 Iron Sucrose
- 1.3.5 Ferric Carboxyl Maltose
- 1.4 Market Segment by Application
- 1.4.1 Global Intraveno(IV) Iron Drugs Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Ambulatory Surgical Centers
- 1.4.4 Diagnostic Centers
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Intraveno(IV) Iron Drugs Market Size
- 2.1.1 Global Intraveno(IV) Iron Drugs Revenue 2014-2025
- 2.1.2 Global Intraveno(IV) Iron Drugs Sales 2014-2025
- 2.2 Intraveno(IV) Iron Drugs Growth Rate by Regions
- 2.2.1 Global Intraveno(IV) Iron Drugs Sales by Regions 2014-2019
- 2.2.2 Global Intraveno(IV) Iron Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Intraveno(IV) Iron Drugs Sales by Manufacturers
- 3.1.1 Intraveno(IV) Iron Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Intraveno(IV) Iron Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Intraveno(IV) Iron Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Intraveno(IV) Iron Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Intraveno(IV) Iron Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Intraveno(IV) Iron Drugs Price by Manufacturers
- 3.4 Key Manufacturers Intraveno(IV) Iron Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Intraveno(IV) Iron Drugs Market
- 3.6 Key Manufacturers Intraveno(IV) Iron Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Low Molecular Weight Iron Dextran Sales and Revenue (2014-2019)
- 4.1.2 Ferric Gluconate Sales and Revenue (2014-2019)
- 4.1.3 Iron Sucrose Sales and Revenue (2014-2019)
- 4.1.4 Ferric Carboxyl Maltose Sales and Revenue (2014-2019)
- 4.2 Global Intraveno(IV) Iron Drugs Sales Market Share by Type
- 4.3 Global Intraveno(IV) Iron Drugs Revenue Market Share by Type
- 4.4 Intraveno(IV) Iron Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Intraveno(IV) Iron Drugs Sales by Application
6 United States
- 6.1 United States Intraveno(IV) Iron Drugs Breakdown Data by Company
- 6.2 United States Intraveno(IV) Iron Drugs Breakdown Data by Type
- 6.3 United States Intraveno(IV) Iron Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Intraveno(IV) Iron Drugs Breakdown Data by Company
- 7.2 European Union Intraveno(IV) Iron Drugs Breakdown Data by Type
- 7.3 European Union Intraveno(IV) Iron Drugs Breakdown Data by Application
8 China
- 8.1 China Intraveno(IV) Iron Drugs Breakdown Data by Company
- 8.2 China Intraveno(IV) Iron Drugs Breakdown Data by Type
- 8.3 China Intraveno(IV) Iron Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Intraveno(IV) Iron Drugs Breakdown Data by Company
- 9.2 Rest of World Intraveno(IV) Iron Drugs Breakdown Data by Type
- 9.3 Rest of World Intraveno(IV) Iron Drugs Breakdown Data by Application
- 9.4 Rest of World Intraveno(IV) Iron Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Intraveno(IV) Iron Drugs Sales by Countries
- 9.4.2 Rest of World Intraveno(IV) Iron Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Allergan
- 10.1.1 Allergan Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Intraveno(IV) Iron Drugs
- 10.1.4 Intraveno(IV) Iron Drugs Product Introduction
- 10.1.5 Allergan Recent Development
- 10.2 AMAG Pharmaceuticals
- 10.2.1 AMAG Pharmaceuticals Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Intraveno(IV) Iron Drugs
- 10.2.4 Intraveno(IV) Iron Drugs Product Introduction
- 10.2.5 AMAG Pharmaceuticals Recent Development
- 10.3 Galenica
- 10.3.1 Galenica Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Intraveno(IV) Iron Drugs
- 10.3.4 Intraveno(IV) Iron Drugs Product Introduction
- 10.3.5 Galenica Recent Development
- 10.4 Actavis
- 10.4.1 Actavis Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Intraveno(IV) Iron Drugs
- 10.4.4 Intraveno(IV) Iron Drugs Product Introduction
- 10.4.5 Actavis Recent Development
- 10.5 American Regent
- 10.5.1 American Regent Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Intraveno(IV) Iron Drugs
- 10.5.4 Intraveno(IV) Iron Drugs Product Introduction
- 10.5.5 American Regent Recent Development
- 10.6 Sanofi
- 10.6.1 Sanofi Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Intraveno(IV) Iron Drugs
- 10.6.4 Intraveno(IV) Iron Drugs Product Introduction
- 10.6.5 Sanofi Recent Development
- 10.7 Luitpold Pharmaceuticals
- 10.7.1 Luitpold Pharmaceuticals Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Intraveno(IV) Iron Drugs
- 10.7.4 Intraveno(IV) Iron Drugs Product Introduction
- 10.7.5 Luitpold Pharmaceuticals Recent Development
- 10.8 Fresenius Medical Care
- 10.8.1 Fresenius Medical Care Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Intraveno(IV) Iron Drugs
- 10.8.4 Intraveno(IV) Iron Drugs Product Introduction
- 10.8.5 Fresenius Medical Care Recent Development
- 10.9 Pharmacosmos
- 10.9.1 Pharmacosmos Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Intraveno(IV) Iron Drugs
- 10.9.4 Intraveno(IV) Iron Drugs Product Introduction
- 10.9.5 Pharmacosmos Recent Development
- 10.10 Vifor Pharma
- 10.10.1 Vifor Pharma Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Intraveno(IV) Iron Drugs
- 10.10.4 Intraveno(IV) Iron Drugs Product Introduction
- 10.10.5 Vifor Pharma Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Intraveno(IV) Iron Drugs Sales Channels
- 11.2.2 Intraveno(IV) Iron Drugs Distributors
- 11.3 Intraveno(IV) Iron Drugs Customers
12 Market Forecast
- 12.1 Global Intraveno(IV) Iron Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Intraveno(IV) Iron Drugs Sales Forecast by Type
- 12.3 Global Intraveno(IV) Iron Drugs Sales Forecast by Application
- 12.4 Intraveno(IV) Iron Drugs Forecast by Regions
- 12.4.1 Global Intraveno(IV) Iron Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Intraveno(IV) Iron Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Intraveno(IV) Iron Drugs . Industry analysis & Market Report on Intraveno(IV) Iron Drugs is a syndicated market report, published as Global (United States, European Union and China) Intraveno(IV) Iron Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Intraveno(IV) Iron Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
